Bioabsorbable osteofixation devices in craniosynostosis. Clinical experience in 216 cases.

INTRODUCTION: The pursuit of bone fixation systems capable of affording appropriate stability for osteosynthesis has gone through several stages from the use of metal wires, plates, and screws to the current stage of bioabsorbable systems. In our Pediatric Neurosurgery Service and Craniofacial Surgery Unit we began employing these systems in June 1997. The object of this paper is to present a review of the bioabsorbable materials most commonly used in pediatric age, and more specifically in treating craniosynostosis, to describe the characteristics of each one of them and our experience.

PATIENTS AND METHODS: From June 1997 to May 2006 we implanted bioabsorbable fixation systems in 216 patients diagnosed with craniosynostosis. Age at treatment ranged between 4 and 24 months (mean age 6.38 months). Brain computed tomography (CT) scans, and three-dimensional (3-D) reconstruction of CT scans were performed before and after treatment. An 82: 18 L-lactic acid: glycolic acid copolymer was used in 92.2% of these cases, and a 70:30 L-lactic acid: D-lactic acid copolymer was used in the remaining 7.8% of cases. The follow-up of the patients ranged between six months and five years.

RESULTS: There was no displacement of bioabsorbable plates or screws in any case. In one case (0.46%), radiological imaging revealed osteolysis underneath the implant eight months after the surgical procedure. Prominences caused by the plates and screws employed were visible in two cases (0.93%). We found fractures in the osteosynthesis mesh in two patients (0.93%). Four patients (1.85%) presented local inflammation. No alterations of cranial morphology secondary to inadequate stability were observed.

CONCLUSIONS: 1) Bioabsorbable fixation systems provide excellent stability during the bone "healing" period, without a higher complication rate than with other systems. 2) They help the bone grafts keep their remodeled shape. 3) They promote reossification by preventing the bone grafts from moving after osteosynthesis. 4) No interference with normal growth of the cranial vault has been observed.